Gossamer Bio Inc.

NASDAQ: GOSS · Real-Time Price · USD
1.96
0.00 (0.00%)
At close: Aug 15, 2025, 1:07 PM

Gossamer Bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
114.7M n/a n/a n/a
Cost of Revenue
n/a 4.38M 4.43M 5.17M
Gross Profit
114.7M -4.38M -4.43M -5.17M
Operating Income
-59.92M -183.76M -218.59M -216.12M
Interest Income
1.78M 2M 1.58M 761K
Pretax Income
-55.63M -179.82M -229.38M -234M
Net Income
-56.53M -179.82M -240.23M -249.08M
Selling & General & Admin
36.13M 38.45M 47.61M 45.78M
Research & Development
138.49M 145.3M 170.92M 170.27M
Other Expenses
n/a n/a 1.51M 799K
Operating Expenses
174.62M 183.76M 218.53M 216.05M
Interest Expense
11.52M 13.51M 13.88M 19.44M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
174.62M 183.76M 218.53M 216.05M
Income Tax Expense
893K n/a 10.85M 15.07M
Shares Outstanding (Basic)
226.23M 225.57M 84.57M 74.84M
Shares Outstanding (Diluted)
226.23M 225.57M 84.57M 74.84M
EPS (Basic)
-0.25 -0.8 -2.84 -3.33
EPS (Diluted)
-0.25 -1.18 -2.84 -3.33
EBITDA
-39.97M -172.15M -211.07M -209.32M
EBIT
-44.12M -173.76M -215.5M -216.05M
Depreciation & Amortization
4.15M 1.61M 4.43M 5.17M